Skip to main content

Table 1 Characteristics of the study population (n = 119)

From: Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study

Age (years)

67 ± 14

Male sex (%)

71 (59.7)

Premorbidities (%)

 

   Chronic arterial hypertension

41 (34.5)

   Coronary heart disease

60 (50.4)

   Congestive heart failure

37 (31.1)

   Chronic atrial fibrillation

13 (10.9)

   Chronic obstructive pulmonary disease

16 (13.4)

   Chronic renal insufficiency

33 (27.7)

   Chronic liver disease

22 (18.5)

   Neoplasm

5 (4.2)

   Obesity/metabolic syndrome

27 (22.7)

Cause of shock (%)

 

   Acute coronary syndrome

76 (63.9)

   Decompensation of chronic cardiomyopathy

30 (25.2)

   Cardiomyopathy of unknown etiology

6 (5)

   Acute viral myocarditis

3 (2.5)

   Acute arrhythmia

1 (0.8)

   Mechanical complication

3 (2.5)

Source of admission (%)

 

   Emergency department

37 (31.1)

   Other hospital

46 (38.7)

   Other intensive care unit

23 (19.7)

   Hospital ward

13 (10.9)

Sequential organ failure assessment

10.8 ± 3.1

Simplified acute physiology score II

52 ± 17

Need for mechanical ventilation (%)

98 (82.4)

   Invasive mechanical ventilation

92 (77.3)

   Non-invasive mechanical ventilation

6 (5)

Need for renal replacement therapy (%)

22 (18.5)

Intra-aortic balloon pump (%)

45 (37.8)

Need for ventricular assist device* (%)

14 (11.8)

Intensive care unit length of stay (days)

7.2 ± 8.7

  1. *Ventricular assist devices include Heart Mate®, Tandem Heart®, Thoratec® or Impella® devices. Initiated more than 24 hours after intensive care unit admission. Data are given as mean values ± standard deviation, if not otherwise indicated.